OpenURL Connection Search

Select item for more details and to access through your institution.

Treatment with nanosomal paclitaxel lipid suspension versus conventional paclitaxel in metastatic breast cancer patients – a multicenter, randomized, comparative, phase II/III clinical study.
Published in:
Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241236442
By:
- Satheesh, Chiradoni Thungappa;
- Taran, Rakesh;
- Singh, Jitendra Kumar;
- Shrivastav, Shanti Prakash;
- Vithalani, Nikunj K.;
- Mukherjee, Kalyan Kusum;
- Nagarkar, Rajnish Vasant;
- Maksud, Tanveer;
- Mehta, Ajay Omprakash;
- Srinivasan, Krishnan;
- Vikranth, Mummaneni;
- Sonawane, Satish Ramkrishna;
- Ahmad, Ateeq;
- Sheikh, Saifuddin;
- Ali, Shoukath M.;
- Patel, Ronak;
- Paithankar, Mahesh;
- Patel, Lav;
- Rajani, Anil;
- Bunger, Deepak
Publication type:
Article
High monocytic MDSC signature predicts multi-drug resistance and cancer relapse in non-Hodgkin lymphoma patients treated with R-CHOP.
Published in:
Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1303959
By:
- Dhar, Sukanya;
- Chakravarti, Mohona;
- Ganguly, Nilanjan;
- Saha, Akata;
- Dasgupta, Shayani;
- Bera, Saurav;
- Sarkar, Anirban;
- Roy, Kamalika;
- Das, Juhina;
- Bhuniya, Avishek;
- Ghosh, Sarbari;
- Sarkar, Madhurima;
- Hajra, Srabanti;
- Banerjee, Saptak;
- Pal, Chiranjib;
- Saha, Bhaskar;
- Mukherjee, Kalyan Kusum;
- Baral, Rathindranath;
- Bose, Anamika
Publication type:
Article
Outcomes of 3-year follow up with induction vs first line chemotherapy in oral cancer patients: An observational hospital-based study.
Published in:
Journal of Cancer Research & Therapeutics, 2024, v. 20, n. 3, p. 1006, doi. 10.4103/jcrt.jcrt_2179_22
By:
- Sahoo, Pranab Kumar;
- Bhowmick, Anup Kumar;
- Sarkar, Sinjini;
- Mahata, Sutapa;
- Pal, Ranita;
- Mistry, Tanuma;
- Ghosh, Sushmita;
- Choudhury, Trisha;
- Kumar, R. Suresh;
- Mondal, Syamsundar;
- Datta, Sriparna;
- Nath, Partha;
- Mukherjee, Kalyan Kusum;
- Nasare, Vilas D.
Publication type:
Article
IFNα2b augments immune responses of cisplatin+5- fluorouracil treated tongue squamous cell carcinoma patients - a preliminary study.
Published in:
Indian Journal of Medical Research, 2012, v. 136, n. 1, p. 54
By:
- Mukherjee, Kalyan Kusum;
- Bose, Anamika;
- Ghosh, Diptendu;
- Sarkar, Koustav;
- Goswami, Shyamal;
- Pal, Smarajit;
- Biswas, Jaydip;
- Baral, Rathindranath
Publication type:
Article

Found: 4

Treatment with nanosomal paclitaxel lipid suspension versus conventional paclitaxel in metastatic breast cancer patients – a multicenter, randomized, comparative, phase II/III clinical study.

High monocytic MDSC signature predicts multi-drug resistance and cancer relapse in non-Hodgkin lymphoma patients treated with R-CHOP.

Outcomes of 3-year follow up with induction vs first line chemotherapy in oral cancer patients: An observational hospital-based study.

IFNα2b augments immune responses of cisplatin+5- fluorouracil treated tongue squamous cell carcinoma patients - a preliminary study.